P17987 (TCPA_HUMAN) Homo sapiens (Human)

T-complex protein 1 subunit alpha UniProtKBInterProSTRINGInteractive Modelling

556 aa; Sequence (Fasta) ; 3 identical sequences: Pan troglodytes: A0A6D2VYN1, G2HIL6; Gorilla gorilla gorilla: G3RDV8

Available Structures

49 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
cryo-EM structure of human TRiC-ADP-AlFx Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
3-539
10016×ADP; 16×MG; 16×AF3;
Human TRiC-tubulin-S3 Heteromer
P07437; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
3-539
10016×ADP; 16×MG; 16×AF3;
cryo-EM structure of human TRiC-ATP-closed state Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
3-539
100
CCT G beta 5 complex closed state 15 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
2-537
10016×ADP; 16×MG; 16×AF3;
CCT G beta 5 complex closed state 14 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
2-537
10016×ADP; 16×MG; 16×AF3;
CCT G beta 5 complex closed state 0 Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
2-537
10016×ADP; 16×MG; 16×AF3;
CCT-G beta 5 complex closed state 7 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
2-537
10016×ADP; 16×MG; 16×AF3;
CCT G beta 5 complex close state 11 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
2-537
10016×ADP; 16×MG; 16×AF3;
CCT G beta 5 complex closed state 12 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
2-537
10016×ADP; 16×MG; 16×AF3;
CCT G beta 5 complex closed state 2 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
2-537
10016×ADP; 16×MG; 16×AF3;
CCT-G beta 5 complex closed state 6 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
2-537
10016×ADP; 16×MG; 16×AF3;
CCT G beta 5 complex closed state 13 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
2-537
10016×ADP; 16×MG; 16×AF3;
CCT-G beta 5 complex closed state 4 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
2-537
10016×ADP; 16×MG; 16×AF3;
CCT G beta 5 complex closed state 9 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
2-537
10016×ADP; 16×MG; 16×AF3;
CCT G beta 5 complex closed state 1 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
2-537
10016×ADP; 16×MG; 16×AF3;
CCT G beta 5 complex closed state 10 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
2-537
10016×ADP; 16×MG; 16×AF3;
CCT G beta 5 complex closed state 3 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
2-537
10016×ADP; 16×MG; 16×AF3;
CCT G beta 5 complex best PhLP1 class Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
2-537
10016×ADP; 16×MG; 16×AF3;
CCT-G beta 5 complex closed state 8 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
2-537
10016×ADP; 16×MG; 16×AF3;
CCT G beta 5 complex closed state 5 Heteromer
O14775; P40227; P48643; P49368; P50990; P50991; P78371; Q13371; Q99832;
2-537
10016×ADP; 16×MG; 16×AF3;
Human TRiC complex in closed state with nanobody Nb18, actin and PhLP2A bound Heteromer
P40227; P48643; P49368; P50990; P50991; P63261; P78371; Q99832; Q9H2J4;
2-537
10016×ADP; 16×MG; 16×AF3;
Human TRiC complex in closed state with nanobody and tubulin bound Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q13885; Q99832;
1-536
10016×ADP; 16×MG; 16×AF3;
The beta-tubulin folding intermediate I Heteromer
P07437; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
2-536
100MG;ADP;AF3;
The beta-tubulin folding intermediate IV Heteromer
P07437; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
2-536
100MG;ADP;AF3;
The beta-tubulin folding intermediate II Heteromer
P07437; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
2-536
100AF3;MG;ADP;
The beta-tubulin folding intermediate III Heteromer
P07437; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
2-536
100MG;ADP;AF3;
hTRiC-hPFD Class3 Heteromer
O15212; O60925; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9;
1-534
100
hTRiC-hPFD Class6 Heteromer
O15212; O60925; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9;
1-534
100
hTRiC-hPFD Class5 Heteromer
O15212; O60925; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9;
1-534
100
hTRiC-hPFD Class1 (No PFD) Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
1-534
100
hTRiC-hPFD Class4 Heteromer
O15212; O60925; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9;
1-534
100
hTRiC-hPFD Class2 Heteromer
O15212; O60925; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9;
1-534
100
Human TRiC-PhLP2A-actin complex in the closed state Heteromer
P40227; P48643; P49368; P50990; P50991; P60709; P78371; Q99832; Q9H2J4;
3-536
100
Human TRiC complex in closed state with nanobody bound (Consensus Map) Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
3-536
10016×ADP; 16×MG; 16×AF3;
Human TRiC/CCT complex with reovirus outer capsid protein sigma-3 Heteromer
P03527; P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
5-536
100ZN;
Human TRiC in ATP/AlFx closed state Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
5-536
100
Human TRiC-PhLP2A complex in the closed state Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832; Q9H2J4;
4-535
10016×ADP; 16×MG; 16×AF3;
Cryo-EM structure of Human TRiC-ATP-open state Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
5-533
100
Cryo-EM structure of human TRiC-NPP state Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
5-533
100
Human TRiC open state Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
5-533
100.0ADP;
Cryo-EM structure of human TRiC-tubulin-S2 Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
5-533
10016×ATP;
cryo-EM structure of human TRiC-ADP Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
5-533
10016×ADP;
Human TRiC-PhLP2A complex in the open state Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832; Q9H2J4;
13-533
10010×ADP;
Cryo-EM structure of human TRiC-tubulin-S1 state Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
14-533
100ADP;
CCT G beta 5 complex intermediate state Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
13-532
100.016×ADP;
Human CCT:mLST8 complex Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
13-532
100.0ADP;
Open state CCT-G beta 5 complex Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
13-532
100.016×ADP;
Human TRiC complex in open state with nanobody bound Heteromer
P40227; P48643; P49368; P50990; P50991; P78371; Q99832;
15-533
100.016×MG; 16×ADP; 12×AF3;
Prefoldin-tubulin-TRiC complex Heteromer
O15212; O60925; P40227; P48643; P49368; P50990; P50991; P61758; P78371; Q99471; Q99832; Q9NQP4; Q9UHV9;
16-531
100ADP;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7nvn.1.Amonomer0.772-536
ADP;AF3;100.00